ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
US Tech 100
18,064.80
0.02%
Dow Jones
38,686.32
1.51%
Brent Oil
81.295
0.00%
Bitcoin
67,693.35
0.32%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Neurochem - Common Shares (MM) (NRMX)

  7. Neurochem - Common Shares (MM) (NRMX) News

NRMX

Neurochem (NRMX)

Neurochem - Common Shares (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NRMX
DateTimeSourceHeadlineSymbolCompany
04/16/200811:57AMEdgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
04/15/20088:00AMPR Newswire (US)At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update oNASDAQ:NRMX
04/11/20084:27PMEdgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
04/11/20082:30PMPR Newswire (US)Media advisory - Neurochem's Annual and Special Meeting of Shareholders April 15, 2008NASDAQ:NRMX
04/11/200812:24PMPR Newswire (US)Neurochem Annual and Special Meeting of shareholdersNASDAQ:NRMX
04/10/200811:26AMEdgar (US Regulatory)Neurochem Inc - Amended Annual Report (foreign private issuer) (40-F/A)NASDAQ:NRMXNeurochem - Common Shares (MM)
03/20/200812:48PMEdgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
03/14/20085:23PMEdgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
03/14/20085:07PMEdgar (US Regulatory)Neurochem Inc - Annual Report (foreign private issuer) (40-F)NASDAQ:NRMXNeurochem - Common Shares (MM)
03/13/20083:25PMEdgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
03/13/20087:00AMPR Newswire (US)Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosisNASDAQ:NRMX
02/22/20082:10PMEdgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
02/21/20087:19PMPR Newswire (US)Neurochem announces departure of two members of management teamNASDAQ:NRMX
02/21/20084:54PMEdgar (US Regulatory)Neurochem Inc - Amended Report of Foreign Issuer (6-K/A)NASDAQ:NRMXNeurochem - Common Shares (MM)
02/21/20083:18PMEdgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
02/20/20087:12PMPR Newswire (US)Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectivesNASDAQ:NRMX
02/15/20083:45PMEdgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
02/13/200812:26PMPR Newswire (US)/C O R R E C T I O N from source -- Neurochem Inc./NASDAQ:NRMX
02/11/20083:55PMEdgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
02/11/200810:46AMPR Newswire (US)Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast liveNASDAQ:NRMX
01/30/20084:26PMEdgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
01/30/20088:00AMPR Newswire (US)Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical businessNASDAQ:NRMX
01/03/20083:59PMEdgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
01/03/20081:08PMPR Newswire (US)Neurochem to present at JPMorgan Healthcare ConferenceNASDAQ:NRMX
12/14/20073:51PMEdgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
12/14/20078:24AMPR Newswire (US)Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosisNASDAQ:NRMX
12/07/20075:25PMEdgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
12/06/20075:09PMPR Newswire (US)Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 reviewNASDAQ:NRMX
12/03/20073:05PMEdgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
11/30/20074:15PMPR Newswire (US)Neurochem announces departure of Dr. Philippe Calais, President, Global BusinessNASDAQ:NRMX
 Showing the most relevant articles for your search:NASDAQ:NRMX

Your Recent History

BIT
BFF
BFF Bank
KOSPI
610012
LEVERAGE GOLD FUTURES ET...
COIN
PHOONUST
Typhoon
COIN
BEEFYBTC
Bank4YOU
BIT
P1S9D6
BNP Paribas Issuance
NASDAQ
ITLA
Itla Capital
USOTC
HRGLF
Hargreaves Lansdown (PK)
COIN
FIREGBP
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved